Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

However, not everyone is willing—or able—to indefinitely commit to GLP-1s.

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

This randomized controlled trial shows that structured moderate-to-vigorous exercise, alone or combined with liraglutide, ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

Glucagon, secreted by pancreatic α-cells, plays a crucial role in glucose metabolism through its counter-regulatory effects ...

The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...

GLP-1 receptor agonist (GLP-1 RA) use, compared with metformin or insulin, is associated with significantly improved survival and lower rates of hospitalization and major complications among patients ...